Aashka Hospitals Ltd (543346) share price, results

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore

	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	24.82	28.42	11.32	11.54	7.41	10.80	12.07	12.36	10.28	10.44	12.57
Expenses	19.41	19.41	12.06	10.80	7.91	9.97	8.44	7.89	10.49	8.33	9.44
Operating Profit	5.41	9.01	-0.74	0.74	-0.50	0.83	3.63	4.47	-0.21	2.11	3.13
OPM %	21.80%	31.70%	-6.54%	6.41%	-6.75%	7.69%	30.07%	36.17%	-2.04%	20.21%	24.90%
Other Income	0.04	0.04	0.09	0.06	3.06	2.61	1.61	0.07	4.20	0.90	1.96
Interest	1.43	1.43	1.23	-0.17	3.17	1.46	1.45	1.02	0.70	0.63	0.55
Depreciation	1.45	1.45	1.44	1.44	1.49	1.47	1.45	1.58	1.37	1.46	1.51
Profit before tax	2.57	6.17	-3.32	-0.47	-2.10	0.51	2.34	1.94	1.92	0.92	3.03
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	17.65%	17.09%	16.49%	14.58%	15.22%	15.51%
Net Profit	2.57	6.17	-3.33	-0.47	-2.10	0.42	1.93	1.62	1.65	0.78	2.56
EPS in Rs	1.43	2.64	-1.42	-0.20	-0.90	0.18	0.82	0.69	0.71	0.33	1.09

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	27.67	27.23	40.69	39.73	18.94	22.87	22.65	23.01
Expenses	18.08	18.41	30.72	31.16	18.59	18.41	18.37	17.77
Operating Profit	9.59	8.82	9.97	8.57	0.35	4.46	4.28	5.24
OPM %	34.66%	32.39%	24.50%	21.57%	1.85%	19.50%	18.90%	22.77%
Other Income	0.06	0.02	0.00	0.13	3.10	4.21	4.26	2.86
Interest	5.75	4.90	3.25	2.96	3.09	2.91	1.72	1.18
Depreciation	2.54	2.56	2.61	2.90	2.93	2.92	2.95	2.97
Profit before tax	1.36	1.38	4.11	2.84	-2.57	2.84	3.87	3.95
Tax %	0.00%	0.00%	0.00%	16.55%	0.00%	17.25%	15.50%	15.70%
Net Profit	1.36	1.38	4.11	2.37	-2.57	2.36	3.27	3.34
EPS in Rs	0.76	0.77	2.28	1.01	-1.10	1.01	1.40	1.43
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

	10 Years	5 Years	3 Years	TTM	1 Year	Last Year
Compounded Sales Growth	%	-11%	7%	2%
Compounded Profit Growth	%	-7%	46%	21%
Stock Price CAGR	%	16%	18%		22%
Return on Equity	%	2%	3%			3%

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	17.16	17.91	18.00	23.37	23.37	23.37	23.37	23.40
Reserves	-1.80	6.28	11.25	73.20	70.55	72.91	76.17	79.87
Borrowings	32.99	30.92	27.87	28.21	29.19	20.39	12.61	8.24
Other Liabilities	5.71	4.93	7.96	4.34	4.92	4.78	3.91	4.33
Total Liabilities	54.06	60.04	65.08	129.12	128.03	121.45	116.06	115.84
Fixed Assets	46.36	44.12	49.49	48.46	45.47	42.78	40.79	41.52
CWIP	0.08	0.00	0.00	0.00	0.05	0.45	0.88	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	7.62	15.92	15.59	80.66	82.51	78.22	74.39	74.32
Total Assets	54.06	60.04	65.08	129.12	128.03	121.45	116.06	115.84

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-0.96	14.50	-62.63	1.01	7.18	9.19	7.79
Cash from Investing Activity	-0.24	-7.98	-1.87	-0.07	-0.63	-1.38	-2.82
Cash from Financing Activity	4.16	-7.97	62.64	1.05	-7.62	-7.20	-3.24
Net Cash Flow	2.96	-1.44	-1.86	1.99	-1.08	0.61	1.73
Free Cash Flow	-1.20	6.52	-64.50	0.94	6.55	7.81	4.97
CFO/OP	-8%	148%	-725%	289%	172%	229%	160%

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	45.64	90.48	65.66	71.84	132.20	76.93	76.06	110.56
Inventory Days	51.35	66.55	30.28	34.97	56.59	48.75	58.63	49.26
Days Payable	296.91	247.49	241.09	101.11	365.00	263.54	130.46	194.50
Cash Conversion Cycle	-199.92	-90.46	-145.15	5.71	-176.21	-137.86	4.23	-34.68
Working Capital Days	-93.26	19.57	-38.48	-34.27	-126.42	-123.21	3.38	103.90
ROCE %		12.14%	13.12%	6.38%	0.42%	4.80%	4.07%	4.05%

	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Promoters	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%	61.28%	61.34%	61.34%
Public	38.72%	38.72%	38.71%	38.72%	38.73%	38.71%	38.71%	38.72%	38.68%	38.67%
No. of Shareholders	2,771	3,245	3,171	2,435	2,066	1,641	1,244	1,174	1,172	1,126

Fundamentals

Market Cap₹ 241 Cr.

Current Price₹ 103

Stock P/E84.7

Book Value₹ 44.1

ROCE4.05 %

ROE2.80 %

Dividend Yield0.00 %

Face Value₹ 10.0

Compounded Sales Growth (TTM)2%

Compounded Profit Growth (TTM)21%

Standalone figures.

Valuation

Market capRs 247 Cr

Enterprise valueRs 265 Cr

P/E (TTM)104.46x

Price to book2.56x

Price to sales10.78x

EV / EBITDA30.56x

EV / EBIT46.08x

EV / sales11.58x

Price to cash flow34.34x

Earnings yield0.96%

P/E, 3-year average63.08x

P/B, 3-year average1.38x

P/E, 5-year average63.08x

P/B, 5-year average1.38x

Profitability

Operating margin (excl. other income)19.50%

Operating margin (incl. other income)37.91%

EBITDA margin37.91%

Pre-tax margin12.42%

Net profit margin10.32%

ROE2.48%

ROCE4.80%

ROA1.89%

ROE, 3-year average1.18%

ROCE, 3-year average3.86%

ROA, 3-year average0.78%

ROE, 5-year average5.18%

ROCE, 5-year average7.37%

ROA, 5-year average2.26%

ROIC (approx.)4.15%

Tax rate17.25%

Other income / net worth4.37%

Growth

Sales growth (latest year)20.75%

Sales CAGR, 3 years-17.47%

Sales CAGR, 5 years-3.74%

Profit CAGR, 3 years-16.88%

Profit CAGR, 5 years11.65%

Per share

EPS (TTM)Rs 1.01

EPS (latest year)Rs 1.01

EPS, 3-year averageRs 0.31

EPS, 5-year averageRs 0.80

Book value per shareRs 41.20

Sales per shareRs 9.79

Cash flow per shareRs 3.07

Free cash flow per shareRs 2.13

Efficiency

Asset turnover0.19x

Fixed asset turnover0.53x

Inventory turnover28.76x

Inventory days13 days

Debtor days77 days

Debtors turnover4.74x

Creditor days194 days

Cash conversion cycle-35 days

Working capital days104 days

Leverage

Total debtRs 20 Cr

Cash and bankRs 2 Cr

Net debtRs 18 Cr

Debt to equity0.21x

Net debt / EBITDA2.12x

Interest coverage1.98x

Owners' fund to total sources79.28%

Debt to assets16.79%

Cash flow

Cash from Operating Activity (latest year)Rs 7 Cr

Cash from Investing Activity (latest year)Rs -1 Cr

Cash from Financing Activity (latest year)Rs -8 Cr

Net Cash Flow (latest year)Rs -1 Cr

Free cash flow (latest year)Rs 5 Cr

FCFE (approx.: FCF + change in debt)Rs -4 Cr

Cash from ops / profit, 5 years-4.27x

Sales to cash flow3.19x

Statement figures

Net sales (TTM)Rs 23 Cr

Net sales (latest year)Rs 23 Cr

Operating profit excl. other income (latest year)Rs 4 Cr

Other income (TTM)Rs 4 Cr

EBITDA (TTM)Rs 9 Cr

PBDT (TTM)Rs 6 Cr

Profit before tax (TTM)Rs 3 Cr

Tax (latest year)Rs 0 Cr

Net profit (TTM)Rs 2 Cr

Net profit (latest year)Rs 2 Cr

Depreciation (TTM)Rs 3 Cr

Interest (TTM)Rs 3 Cr

Cost of goods sold (latest year)Rs 11 Cr

Total expenditure (latest year)Rs 18 Cr

Total income (latest year)Rs 27 Cr

Share capitalRs 23 Cr

ReservesRs 73 Cr

Shareholders' fundsRs 96 Cr

Total assetsRs 121 Cr

Net blockRs 43 Cr

Capital work in progressRs 0 Cr

ReceivablesRs 5 Cr

InventoryRs 0 Cr

Other liabilitiesRs 5 Cr

Shares outstanding (crore)2.34

Ownership

Promoter holding61.34% (+0.06 in a year)

Computed by MarketFriction from the standalone statements. Returns use average balances.

P/E 104.5 is at the 82th percentile of its own 4.2-year range (median 80.2, low 26.7, high 118.9).

P/B 2.56 is at the 32th percentile (median 3.68).

Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.

Period	543346	Nifty 50	Difference
1 week	+24.3%	-2.8%	+27.0 pts
1 month	+49.6%	-6.8%	+56.4 pts
3 years	+70.7%	+14.2%	+56.5 pts
5 years	+112.3%	+27.9%	+84.4 pts

Red flags

F-score 8 of 8

explain	Weak cash conversion Cash from operations was -2520% of net profit over the last 3 years
explain	Share dilution Share count up 0% in a year, 30% in three
look	Profit leans on other income Other income was 148% of pre-tax profit in 2026

Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Mar 2026

Sales ₹13 Cr +4.1% vs Mar 2024. Net profit ₹3 Cr +32.6%.

Activity

Compare

Company	Mcap (Cr)	P/E	ROCE
Apollo Hospitals Enterprise Ltd	124,503	59.2	17.4 %
Manipal Health Enterprises Ltd	98,357	111	12.1 %
Max Healthcare Institute Ltd	95,589	63.8	14.7 %
Aster DM Quality Care Ltd	63,976	177	11.6 %
Fortis Healthcare Ltd	62,058	58.2	13.4 %
Global Health Ltd	38,048	66.4	17.4 %
Narayana Hrudayalaya Ltd	36,579	42.4	15.5 %
Krishna Institute of Medical Sciences Ltd	32,336	155	9.50 %
Dr Agarwals Health Care Ltd	15,701	106	10.9 %
Rainbow Childrens Medicare Ltd	13,892	48.5	17.4 %
Park Medi World Ltd	11,898	42.8	19.5 %
Yatharth Hospital & Trauma Care Services Ltd	10,676	58.9	12.9 %
Healthcare Global Enterprises Ltd	10,505	218	8.30 %
Jupiter Life Line Hospitals Ltd	8,591	44.9	14.8 %
Kovai Medical Center & Hospital Ltd	6,579	25.7	22.6 %

No bulk or block deals on record.

No corporate actions on record.

No announcements in our files yet.

Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.

No short selling reported to NSE in our files.

Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.

Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Aashka Hospitals Ltd?

Aashka Hospitals Ltd (543346) has a market capitalisation of Rs 241 Cr. at the 2026-10-01 close.

What is the P/E ratio of Aashka Hospitals Ltd?

Aashka Hospitals Ltd trades at a P/E of 84.7 on trailing twelve-month profit, at the 2026-10-01 close.

What were Aashka Hospitals Ltd's latest quarterly results?

In the Mar 2026 quarter, Aashka Hospitals Ltd sales was Rs 13 Cr (+4.1% vs Mar 2024) and net profit was Rs 3 Cr.